Volume | 825,462 |
|
|||||
Noticias | (1) | ||||||
Máximo del Dia | 4.30 | Mínimo Máximo |
|||||
Minimo del Dia | 3.50 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Eagle Pharmaceuticals Inc | EGRX | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
4.30 | 3.50 | 4.30 | 3.81 | 4.37 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
3,430 | 825,462 | US$ 3.79 | US$ 3,124,899 | - | 3.50 - 23.52 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
18:32:50 | 5 | US$ 3.74 | USD |
Información Financiera Eagle Pharmaceuticals Inc EGRX
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
49.35M | 12.99M | - | 316.61M | 35.64M | 2.74 | 1.38 |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Eagle Pharmaceuticals Inc EGRX
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
22/5/2024 | 08:08 | Edgar (US Regulatory) | Form 8-K - Current report |
15/5/2024 | 08:29 | Edgar (US Regulatory) | Form 8-K - Current report |
10/5/2024 | 16:27 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form.. |
08/3/2024 | 15:49 | Edgar (US Regulatory) | Form 8-K - Current report |
01/3/2024 | 15:40 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
01/3/2024 | 06:35 | Edgar (US Regulatory) | Form 8-K - Current report |
29/2/2024 | 19:23 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
29/2/2024 | 15:44 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
29/2/2024 | 07:09 | Edgar (US Regulatory) | Form 8-K - Current report |
14/2/2024 | 16:09 | Edgar (US Regulatory) | Form SC 13D - General statement of acquisition of beneficial.. |
13/2/2024 | 14:53 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
13/2/2024 | 07:50 | Edgar (US Regulatory) | Form 8-K - Current report |
Histórico de Datos EGRX
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 4.75 | 4.98 | 3.50 | 4.61 | 84,027 | -1.01 | -21.26% |
1 Month | 4.77 | 4.98 | 3.50 | 4.43 | 108,843 | -1.03 | -21.59% |
3 Months | 6.43 | 6.81 | 3.50 | 5.06 | 134,097 | -2.69 | -41.84% |
6 Months | 9.05 | 9.10 | 3.50 | 5.25 | 219,560 | -5.31 | -58.67% |
1 Year | 21.27 | 23.52 | 3.50 | 10.43 | 188,254 | -17.53 | -82.42% |
3 Years | 41.60 | 58.25 | 3.50 | 27.45 | 153,820 | -37.86 | -91.01% |
5 Years | 55.28 | 64.94 | 3.50 | 35.99 | 150,553 | -51.54 | -93.23% |